Chronic News and Research

RSS

Serum phosphorus levels can help predict risk of ESRD in African Americans with CKD

An increase in serum phosphorus levels in African Americans with chronic kidney disease (CKD) is associated with faster progression to kidney failure, known as end-stage renal disease (ESRD), according to new research presented at ASN Kidney Week 2015 November 3-8 in San Diego, CA. Previously confirmed in primarily Caucasian populations, the Indiana University School of Medicine study confirms serum phosphorus is linked to ESRD risk in African Americans.

18 Nov 2015

Study finds young whites more optimistic about likelihood of living to 35 than minority peers

A new study of young people finds that, with one exception, whites are more optimistic -- sometimes drastically so -- than their minority peers about their likelihood of living to 35.

18 Nov 2015

Johns Hopkins scientists use gene-based tests to distinguish precancerous cysts from harmless cysts

In a "look-back" analysis of data stored on 130 patients with pancreatic cysts, scientists at Johns Hopkins have used gene-based tests and a fixed set of clinical criteria to more accurately distinguish precancerous cysts from those less likely to do harm. The findings may eventually help some patients in real time safely avoid surgery to remove harmless cysts.

18 Nov 2015

USC discoveries propose promising method to eliminate pain associated with tooth decay

Dual discoveries at USC propose a promising method to regrow nonliving hard tissue, lessening or even eliminating pain associated with tooth decay, which the National Institutes of Health calls the most prevalent chronic disease.

18 Nov 2015

Positive data from AbbVie's HCV clinical development program presented at The Liver Meeting of AASLD

AbbVie, a global biopharmaceutical company, today announced data from the SURVEYOR studies of its investigational HCV regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, that show high rates of sustained virologic response at 12 weeks post-treatment (SVR 12) in non-cirrhotic patients with chronic hepatitis C virus (HCV) infection.

17 Nov 2015

Nearly 50% of Medicaid patients infected with hepatitis C denied coverage for life-saving antiviral drugs

Nearly 50 percent of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies because they weren't considered "a medical necessity" or because the patients tested positive for alcohol/drugs, among other reasons, according to new Penn Medicine research.

17 Nov 2015

TTUHSC nephrologists to help find new treatment for lupus nephritis

Nephrologists at Texas Tech University Health Science Center El Paso have been invited to participate in a national consortium that's investigating the key causes of lupus nephritis -- an autoimmune disease that can cause kidney failure.

17 Nov 2015

Negative impact of high-fat diet on red blood cells may promote development of cardiovascular disease

University of Cincinnati researchers have discovered the negative impact a high fat diet has on red blood cells and how these cells, in turn, promote the development of cardiovascular disease.

17 Nov 2015

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

The International Association for the Study of Lung Cancer commends the U.S. Food and Drug Administration's (FDA) decision to grant accelerated approval for osimertinib (Tagrisso), an oral medication for advanced non-small cell lung cancer (NSCLC) patients with a specific epidermal growth factor receptor (EGFR) mutation (T790M) and following progression after previous EGFR inhibitor therapies.

17 Nov 2015

Research collaboration aims to develop new drug for slow-healing chronic wounds

The biotech company Omnio based in Swedish Umeå, and led by researcher Tor Ny at Umeå University, launches a research collaboration with the Canadian pharmaceutical company ProMetic to develop a new drug for slow-healing chronic wounds. The collaboration includes funding for clinical studies of a drug based on the blood plasma protein plasminogen.

15 Nov 2015

Pathophysiological biomarkers predict PAH prognosis

Researchers have identified three biomarkers that signify an increased risk of death or requirement for lung transplantation in patients with pulmonary arterial hypertension.

13 Nov 2015

Drug combination produces long-term responses in patients with mantle cell lymphoma

New research from Moffitt Cancer Center and its collaborators find that the drug combination rituximab plus lenalidomide was effective and produced long-term responses in patients with mantle cell lymphoma.

13 Nov 2015

Older populations in rural areas face special health care challenges

A new study of adults ages 85 or older has found that rural residents have significantly higher levels of chronic disease, take more medications, and die several years earlier than their urban counterparts.

13 Nov 2015

Angina in women linked with abnormal heart blood flow

Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients, a new Cedars-Sinai Heart Institute study shows.

12 Nov 2015

Montefiore and Einstein researchers awarded $14 million PCORI grant for hepatitis C research

A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.

11 Nov 2015

Chronic News and Research

Serum phosphorus levels can help predict risk of ESRD in African Americans with CKD

Study finds young whites more optimistic about likelihood of living to 35 than minority peers

Johns Hopkins scientists use gene-based tests to distinguish precancerous cysts from harmless cysts

USC discoveries propose promising method to eliminate pain associated with tooth decay

Positive data from AbbVie's HCV clinical development program presented at The Liver Meeting of AASLD

Nearly 50% of Medicaid patients infected with hepatitis C denied coverage for life-saving antiviral drugs

TTUHSC nephrologists to help find new treatment for lupus nephritis

Negative impact of high-fat diet on red blood cells may promote development of cardiovascular disease

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

Research collaboration aims to develop new drug for slow-healing chronic wounds

Pathophysiological biomarkers predict PAH prognosis

Drug combination produces long-term responses in patients with mantle cell lymphoma

Older populations in rural areas face special health care challenges

Angina in women linked with abnormal heart blood flow

Montefiore and Einstein researchers awarded $14 million PCORI grant for hepatitis C research

Advances in nanofilter technology may lead to surgically implantable, artificial kidney

Study finds high prevalence of dehydration in older people living in UK care homes

Study shows mindfulness meditation reduces pain more effectively than placebo

Heart of the Rockies Regional Medical Center selects Aprima EHR

Women need different treatment from men with addiction, says McMaster University-led study

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News